HAWAII — Patients For Affordable Drugs Now kicks off a campaign today calling on Rep. Ed Case (HI-01) to support swift passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate lower prices. The campaign includes digital advertising and grassroots advocacy to enable constituents to contact Rep. Case and urge him to stand with Hawaii patients and support H.R. 3.
“Our message to Rep. Case is clear: You have a choice. You can stand with Big Pharma, which is fighting against lower drug prices for your constituents, or stand with Hawaii patients. Now is the moment to show that you will fight for patients,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Hawaii residents need Rep. Case to push for passage of H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching simultaneously in 42 House districts across 22 states and in D.C. It comes on the heels of Big Pharma’s recent attack adloaded with lies about H.R. 3.